N(G)-Methylarginines: Biosynthesis, Biochemical Function and Metabolism
Overview
Affiliations
N(G)-Methylarginines (N(G)-monomethylarginine, N(G), N(G)-dimethylarginine and N(G), N'(G)-dimethylarginine) occur widely in nature in either proteinbound or in free states. They are posttranslationally synthesized by a group of enzymes called protein methylase I with S-adenosyl-L-methionine as the methyl donor. The enzymes are highly specific not only towards arginine residues but also towards the protein species. Since transmethylation reaction is energy-dependent in the form of S-adenosyl-L-methionine and is catalyzed a group of highly specific enzymes, it is quite logical to assume that the enzymatic methylation of protein-bound arginine residues play an important role in the regulation of the function and/or metabolism of the protein. When determined with histones asin vitro substrates, protein methylase I activity parallels closely the degree of cell proliferation, and the myelin basic protein (MBP)-specific protein methylase I activity decreases drastically in dysmyelinating mutant mouse brain during myelinating period, suggesting an important role played in the formation and/or maintenance of myelin. When the methylated proteins are degraded by intracellular proteolytic enzymes, free N(G)-methylarginines are generated. Some of these free N(G)-methylarginines, particularly N(G)-monomethylarginine, are extensively metabolized by decarboxylation, hydrolysis, transfer of methylamidine and deimination reaction. Recent experiment demonstrates that some of the N(G)-methylarginines may be involved in the neutralization of activity of nitric oxide (NO) which has attracted a great deal of attention as vascular smooth muscle relaxation factor.
Plausible diagnostic value of urinary isomeric dimethylarginine ratio for diabetic nephropathy.
Parmar D, Bhattacharya N, Kannan S, Vadivel S, Pandey G, Ghanate A Sci Rep. 2020; 10(1):2970.
PMID: 32076062 PMC: 7031402. DOI: 10.1038/s41598-020-59897-1.
Cardiovascular Disease, the Nitric Oxide Pathway and Risk of Cognitive Impairment and Dementia.
Stephan B, Harrison S, Keage H, Babateen A, Robinson L, Siervo M Curr Cardiol Rep. 2017; 19(9):87.
PMID: 28801790 PMC: 5554286. DOI: 10.1007/s11886-017-0898-y.